Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants

Retrovirology
Steven J SmithStephen H Hughes

Abstract

Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are a class of antiretroviral compounds that bind in an allosteric binding pocket in HIV-1 RT, located about 10 Å from the polymerase active site. Binding of an NNRTI causes structural changes that perturb the alignment of the primer terminus and polymerase active site, preventing viral DNA synthesis. Rilpivirine (RPV) is the most recent NNRTI approved by the FDA, but like all other HIV-1 drugs, suboptimal treatment can lead to the development of resistance. To generate better compounds that could be added to the current HIV-1 drug armamentarium, we have developed several RPV analogs to combat viral variants that are resistant to the available NNRTIs. Using a single-round infection assay, we identified several RPV analogs that potently inhibited a broad panel of NNRTI resistant mutants. Additionally, we determined that several resistant mutants selected by either RPV or Doravirine (DOR) caused only a small increase in susceptibility to the most promising RPV analogs. The antiviral data suggested that there are RPV analogs that could be candidates for further development as NNRTIs, and one of the most promising compounds was modeled in the NNRTI binding pocket. This model c...Continue Reading

References

Apr 1, 1995·Nature Structural Biology·R EsnoufD Stuart
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·K RittingerR S Goody
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·S G SarafianosE Arnold
May 24, 2001·Journal of Molecular Biology·Y HsiouE Arnold
Dec 22, 2007·Journal of Medicinal Chemistry·Xue Zhi ZhaoTerrence R Burke
Jan 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kalyan DasEddy Arnold
Jul 28, 2010·Journal of Virology·Michael E AbramStephen H Hughes
Apr 7, 2011·JAMA : the Journal of the American Medical Association·Jonathan Z LiDaniel R Kuritzkes
Jan 24, 2012·Nature Structural & Molecular Biology·Kalyan DasEddy Arnold
Sep 8, 2012·The Journal of Biological Chemistry·Kamalendra SinghStefan G Sarafianos
Apr 23, 2013·Current Opinion in Virology·Kalyan Das, Eddy Arnold
Apr 23, 2013·Current Opinion in Virology·Kalyan Das, Eddy Arnold
Aug 22, 2013·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Asa M MargolisAndrew Stolbach
Jan 1, 2014·Antimicrobial Agents and Chemotherapy·Ming-Tain LaiMichael D Miller
Apr 22, 2014·Journal of Visualized Experiments : JoVE·Steven J Smith, Stephen H Hughes
Jun 4, 2015·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Andrew StolbachPaul Pham

❮ Previous
Next ❯

Citations

Mar 11, 2018·Biochemistry. Biokhimii︠a︡·V T Valuev-Elliston, S N Kochetkov
Feb 1, 2020·Science·Dario Oliveira PassosDmitry Lyumkis
Apr 29, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Steven J SmithStephen H Hughes

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligonucleotides

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.